As of Thursday, January 08, Vanda Pharmaceuticals Inc.’s VNDA share price has dipped by 10.93%, which has investors ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

AI in 2026 faces limits to scaling, new innovation beyond large models, rising enterprise adoption and mounting pressure on ...

Cybin Inc. (the "Company") doing business as Helus Pharmatm (Cboe CA: HELP) ("Helus Pharma"), a clinical stage pharmaceutical company committed to helping minds heal by developing NSAs, today ...

As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...

Applicants are not supposed to use AI to write college essays. But colleges are using AI to help assess applications. At ...

The Middle East & Africa Sandstone Market was valued at USD 120 million in 2024 and is expected to grow at a strong CAGR of ...

U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated ...

A judge is weighing whether to toss a lawsuit that takes aim at Hampton’s property revaluation — and the entire New Hampshire ...

It’s for cases like Mark’s and the many out there that I’m especially disappointed with the latest White Paper from the ...

U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second quarte ...

Think back to middle school algebra, like 2 a + b. Those letters are parameters: Assign them values and you get a result. In ...